| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
| 06/29/2004 | US6756376 Preventing fatty acid release |
| 06/29/2004 | US6756374 Diaminothiazoles having antiproliferative activity |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756364 Method of reducing gastrointestinal side effects associated with orlistat treatment |
| 06/29/2004 | US6756229 Human liver-derived cultured cell lines useful in, for example, analyzing an enzyme participating in the metabolism of xenobiotics or endogenous substrates |
| 06/29/2004 | US6756053 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 06/29/2004 | CA2293815C Film-coated tablet for improved upper gastrointestinal tract safety |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2234936C Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
| 06/29/2004 | CA2178604C Novel imidazole derivative and process for producing the same |
| 06/29/2004 | CA2161256C Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052462A1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 06/24/2004 | WO2004052399A1 Composition for topical anesthesia |
| 06/24/2004 | WO2004052379A1 Antidiarrheal composition |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004052338A1 Body cavity washer, device for washing body cavity and method of washing body cavity |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003072056A3 Intranasal administration of mc4-r agonists |
| 06/24/2004 | WO2003053966A8 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2003014309A3 Interleukin-1 receptors in the treatment of diseases |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002092758A9 Gastrokines and derived peptides including inhibitors |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | WO2002036072A3 Method for short-term and long-term drug dosimetry |
| 06/24/2004 | US20040122235 such as N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; for treating diseases in which increasing glucokinase activity is beneficial (diabetes) |
| 06/24/2004 | US20040122218 Pyrrolopyridine potassium channel openers |
| 06/24/2004 | US20040122125 Lactone compounds as novel photoinitiators |
| 06/24/2004 | US20040122085 Compounds based on 1-oxoisochroman or - phthalan such as phyllodulcin and hydrangenol; food, beverage and feed additives; alcohol abuse |
| 06/24/2004 | US20040122076 The use of 1-(iso)indolylsulfonamido-),4-(alkylamido-)benzenes and derivatives as 5-Ht6receptor antagonists; Alzheimer's disease; neurodegenerative diseases; prophylaxis |
| 06/24/2004 | US20040122056 dissolving crude omeprazole in a solvent or a mixture of solvents in which omeprazole is freely soluble, and precipitating crystal form of omeprazole with a solvent in which omeprazole is poorly soluble. |
| 06/24/2004 | US20040122052 Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group or derivative; selectively inhibit TNF alpha, useful in treating inflammation and effecting relaxation of airway smooth muscle |
| 06/24/2004 | US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis |
| 06/24/2004 | US20040122047 Substituted tetrahydroisoquinolines |
| 06/24/2004 | US20040122043 Imidazopyridine compounds as 5-HT4 receptor agonists |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | US20040122002 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 06/24/2004 | US20040122001 Pharmaceutical compounds |
| 06/24/2004 | US20040121998 CRF antagonistic quino- and quinazolines |
| 06/24/2004 | US20040121993 for the reduction of cholesterol in blood, and treatment of fatty liver, hyperglycemia and diabetes |
| 06/24/2004 | US20040121979 Pharmaceutically active uridine esters |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121962 Prodrugs of excitatory amino acids |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121029 plant extracts; synergistic |
| 06/24/2004 | US20040121004 protecting the gastrointestinal tract from non-steroidal antiinflammatory drug therapy by administering a NSAID in combination with a buffer and a proton pump inhibitor in a single non-enterically coated dosage form |
| 06/24/2004 | US20040120987 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 06/24/2004 | US20040120986 acidic beverages and oral healthcare compositions; use of calcium in such compositions to alleviate or prevent the tooth damage associated with the consumption of acid |
| 06/24/2004 | US20040120984 Compositions comprising dietary fat complexer and methods for their use |
| 06/24/2004 | US20040120963 bacteria belongs to the genus Megasphaera or Mitsuokella |
| 06/24/2004 | US20040120936 Enhanced composition for treatment of obesity |
| 06/24/2004 | CA2510623A1 Body cavity washer, device for washing body cavity and method of washing body cavity |
| 06/23/2004 | EP1431293A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430903A1 Use of proteasome inhibitors for the treatment of viral infections |
| 06/23/2004 | EP1430895A1 Novel substituted benzimidazole dosage forms and method of using same |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430892A1 Aqueous ecabet sodium solution preparation |
| 06/23/2004 | EP1430304A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 06/23/2004 | EP1430157A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/23/2004 | EP1430144A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430043A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 06/23/2004 | EP1430025A1 Methods and compositions for treating or preventing bacterial infection |
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1429808A1 Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 06/23/2004 | EP1429807A2 Combination of a nsaid and a pde-4 inhibitor |
| 06/23/2004 | EP1429799A2 Kgf polypeptide compositions |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429770A1 New formulations and use thereof |
| 06/23/2004 | EP1429769A1 New formulations and use thereof |
| 06/23/2004 | EP1429766A1 Pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/23/2004 | EP1429730A2 Opioid formulations having reduced potential for abuse |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1353906B1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1237851A4 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1214061B1 Use of docetaxel for treating hepatocellular carcinoma |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |